Bioinformatics Market Size 2024-2028
The bioinformatics market size is forecast to increase by USD 13.2 billion at a CAGR of 16.59% between 2023 and 2028.
The market is experiencing significant growth, driven by the rapid advancements in genetic sequencing technology and the development of sophisticated bioinformatics tools for Next-Generation Sequencing (NGS). These innovations have led to a dramatic reduction in the cost of genetic sequencing, making it accessible to a wider range of researchers and organizations. However, this market is not without challenges. The shortage of trained laboratory professionals with expertise in bioinformatics and data analysis poses a significant barrier to the effective utilization of these advanced technologies. Companies seeking to capitalize on market opportunities must invest in training and development programs to address this talent gap.
Additionally, the increasing volume and complexity of genomic data require scalable and efficient bioinformatics solutions. Strategic partnerships, collaborations, and acquisitions can help companies overcome these challenges and gain a competitive edge in the market. Overall, the market presents significant opportunities for growth, particularly in areas such as personalized medicine, agricultural biotechnology, and environmental research. Companies that can effectively address the talent shortage and provide scalable, efficient solutions will be well-positioned to succeed in this dynamic and evolving market.
What will be the Size of the Bioinformatics Market during the forecast period?
Request Free Sample
The bioinformatics market, at the intersection of biology and computer science, is undergoing rapid growth, driven by next-generation sequencing (NGS), artificial intelligence (AI), and cloud computing. Clinical laboratories and research institutions leverage NGS for biomarker discovery, genetic testing, and protein sequencing, advancing precision medicine and population genetics. Bioinformatic pipelines and high-throughput screening manage omics data, supporting computational biology, evolutionary biology, and biomedical engineering.
Phylogenetic analysis and biological databases fuel scientific collaboration, while open access and cloud computing enhance data sharing. However, data security and data privacy remain critical challenges amid regulatory complexities. Biotechnology startups and digital health firms invest in single-cell sequencing, sequence alignment, and synthetic biology, developing mobile health applications and wearable devices.
Big data, gene editing, and genome editing drive innovation in biotechnology investment, while wet lab experiments complement in silico analyses. Market dynamics include rising demand for precision medicine, biotechnology startups, and digital health, with AI and NGS transforming clinical laboratories and scientific publications. Staying ahead requires addressing data privacy and embracing computational biology trends.
How is this Bioinformatics Industry segmented?
The bioinformatics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Application
Molecular phylogenetics
Proteomics
Metabolomics
Product
Platforms
Tools
Services
Genomics
Chemoinformatics & Drug Design
Others
Technology
Sequence Analysis
Data Warehousing
Structural Analysis
Geography
North America
US
Canada
Europe
France
Germany
UK
Middle East and Africa
UAE
APAC
China
India
Japan
South America
Brazil
By Application Insights
The molecular phylogenetics segment is estimated to witness significant growth during the forecast period.
In the realm of bioinformatics, molecular phylogenetics holds a pivotal position, particularly in the global market. This subfield of bioinformatics utilizes molecular data to elucidate the evolutionary relationships among various species. Its applications span numerous research domains, such as drug discovery, disease diagnosis, and conservation biology. One prominent area of application is the study of viral evolution. By deciphering the molecular data of diverse virus strains, researchers can trace their evolutionary history and gain valuable insights into their origins and transmission patterns. Next-generation sequencing technologies have significantly advanced molecular phylogenetics, enabling the analysis of vast amounts of genetic data.
Artificial intelligence and machine learning algorithms further enhance the accuracy and efficiency of these analyses. Clinical laboratories and research institutions employ these tools for genetic testing and biomarker discovery, driving the market's growth. Bioinformatics tools
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The dataset consists of 1763 observations, each representing a unique patient, and 12 different attributes associated with heart disease. This dataset is a critical resource for researchers focusing on predictive analytics in cardiovascular diseases.
Variables Overview: 1. Age: A continuous variable indicating the age of the patient. 2. Sex: A categorical variable with two levels ('Male', 'Female'), indicating the gender of the patient. 3. CP (Chest Pain type): A categorical variable describing the type of chest pain experienced by the patient, with categories such as 'Asymptomatic', 'Atypical Angina', 'Typical Angina', and 'Non-Angina'. 4. TRTBPS (Resting Blood Pressure): A continuous variable indicating the resting blood pressure (in mm Hg) on admission to the hospital. 5. Chol (Serum Cholesterol): A continuous variable measuring the serum cholesterol in mg/dl. 6. FBS (Fasting Blood Sugar): A binary variable where 1 represents fasting blood sugar > 120 mg/dl, and 0 otherwise. 7. Rest ECG (Resting Electrocardiographic Results): Categorizes the resting electrocardiographic results of the patient into 'Normal', 'ST Elevation', and other categories. 8. Thalachh (Maximum Heart Rate Achieved): A continuous variable indicating the maximum heart rate achieved by the patient. 9. Exng (Exercise Induced Angina): A binary variable where 1 indicates the presence of exercise-induced angina, and 0 otherwise. 10. Oldpeak (ST Depression Induced by Exercise Relative to Rest): A continuous variable indicating the ST depression induced by exercise relative to rest. 11. Slope (Slope of the Peak Exercise ST Segment): A categorical variable with levels such as 'Flat', 'Up Sloping', representing the slope of the peak exercise ST segment. 14. Target: A binary target variable indicating the presence (1) or absence (0) of heart disease.
Descriptive Statistics: The patients' age ranges from 29 to 77 years, with a mean age of approximately 54 years. The resting blood pressure spans from 94 to 200 mm Hg, and the average cholesterol level is about 246 mg/dl. The maximum heart rate achieved varies widely among patients, from 71 to 202 beats per minute.
Importance for Research: This dataset provides a comprehensive view of various factors that could potentially be linked to heart disease, making it an invaluable resource for developing predictive models. By analyzing relationships and patterns within these variables, researchers can identify key predictors of heart disease and enhance the accuracy of diagnostic tools. This could lead to better preventive measures and treatment strategies, ultimately improving patient outcomes in the realm of cardiovascular health
Background: Attribution to the original contributor upon reuse of published data is important both as a reward for data creators and to document the provenance of research findings. Previous studies have found that papers with publicly available datasets receive a higher number of citations than similar studies without available data. However, few previous analyses have had the statistical power to control for the many variables known to predict citation rate, which has led to uncertain estimates of the "citation benefit". Furthermore, little is known about patterns in data reuse over time and across datasets. Method and Results: Here, we look at citation rates while controlling for many known citation predictors, and investigate the variability of data reuse. In a multivariate regression on 10,555 studies that created gene expression microarray data, we found that studies that made data available in a public repository received 9% (95% confidence interval: 5% to 13%) more citations th...
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Figures and survey data from forthcoming pre-print:
In a 2016 survey of 704 National Science Foundation (NSF) Biological Sciences Directorate principle investigators (BIO PIs), nearly 90% indicated they are currently or will soon be analyzing large data sets. BIO PIs considered a range of computational needs important to their work—including high performance computing (HPC), bioinformatics support, multi-step workflows, updated analysis software, and the ability to store, share, and publish data. Previous studies in the U.S. and Canada emphasized infrastructure needs. However, BIO PIs said the most pressing unmet needs are training in data integration, data management, and scaling analyses for HPC – acknowledging that data science skills will be required to build a deeper understanding of life.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Keynote presentation by Rebecca Boyles, Senior Manager, Bioinformatics and Data Science from RTI International presented at Better Science through Better Data event. The video recording, slides and scribes are included.
https://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The global biological software market is experiencing robust growth, driven by the increasing adoption of advanced technologies in life sciences research and healthcare. The market, estimated at $2.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of approximately 12% from 2025 to 2033, reaching an estimated market value of $7 billion by 2033. This expansion is fueled by several key factors: the escalating demand for high-throughput data analysis in genomics and proteomics, the rising prevalence of chronic diseases necessitating advanced diagnostic tools, and the growing adoption of cloud-based solutions for enhanced collaboration and accessibility. Furthermore, the continuous development of sophisticated algorithms and user-friendly interfaces is making biological software more accessible to a wider range of researchers and clinicians. The segment encompassing experimental design and data analysis software holds a significant market share, reflecting the crucial role of computational tools in optimizing research workflows and extracting meaningful insights from complex biological datasets. North America currently dominates the market, owing to the robust presence of established biotechnology companies and a well-funded research infrastructure. However, Asia-Pacific is expected to witness significant growth in the coming years due to the expanding healthcare sector and increasing government investments in research and development. Market restraints include the high cost of software licenses, the requirement for specialized training to effectively utilize these tools, and the potential challenges associated with data security and integration across different platforms. Nevertheless, the ongoing innovation in software capabilities, coupled with the increasing adoption of subscription-based models and cloud-based solutions, is expected to mitigate these constraints. The competitive landscape is characterized by a mix of established players like Thermo Fisher Scientific and DNASTAR, along with smaller specialized companies offering niche solutions. This dynamic competitive environment fosters innovation and drives the development of advanced biological software solutions tailored to the specific needs of diverse research and clinical applications. Future growth will be influenced by factors such as advancements in artificial intelligence and machine learning within the software, integration with laboratory automation systems, and increasing collaboration between software providers and research institutions.
Attribution-NonCommercial-NoDerivs 3.0 (CC BY-NC-ND 3.0)https://creativecommons.org/licenses/by-nc-nd/3.0/
License information was derived automatically
The COVID-19 pandemic has shown that bioinformatics--a multidisciplinary field that combines biological knowledge with computer programming concerned with the acquisition, storage, analysis, and dissemination of biological data--has a fundamental role in scientific research strategies in all disciplines involved in fighting the virus and its variants. It aids in sequencing and annotating genomes and their observed mutations; analyzing gene and protein expression; simulation and modeling of DNA, RNA, proteins and biomolecular interactions; and mining of biological literature, among many other critical areas of research. Studies suggest that bioinformatics skills in the Latin American and Caribbean region are relatively incipient, and thus its scientific systems cannot take full advantage of the increasing availability of bioinformatic tools and data. This dataset is a catalog of bioinformatics software for researchers and professionals working in life sciences. It includes more than 300 different tools for varied uses, such as data analysis, visualization, repositories and databases, data storage services, scientific communication, marketplace and collaboration, and lab resource management. Most tools are available as web-based or desktop applications, while others are programming libraries. It also includes 10 suggested entries for other third-party repositories that could be of use.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
When we look at the rapid growth of scientific databases on the Internet in the past decade, we tend to take the accessibility and provenance of the data for granted. As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. This work could also be extended to the computational models derived from such data. We suggest that scientists in the future will need to consider data licensing before they embark upon re-using such content in databases they construct themselves.
https://www.myvisajobs.com/terms-of-service/https://www.myvisajobs.com/terms-of-service/
A dataset that explores Green Card sponsorship trends, salary data, and employer insights for bioinformatics, biotechnology, computer science in the U.S.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Datasets, conda environments and Softwares for the course "Population Genomics" of Prof Kasper Munch. This course material is maintained by the health data science sandbox. This webpage shows the latest version of the course material.
The data is connected to the following repository: https://github.com/hds-sandbox/Popgen_course_aarhus. The original course material from Prof Kasper Munch is at https://github.com/kaspermunch/PopulationGenomicsCourse.
Description
The participants will after the course have detailed knowledge of the methods and applications required to perform a typical population genomic study.
The participants must at the end of the course be able to:
The course introduces key concepts in population genomics from generation of population genetic data sets to the most common population genetic analyses and association studies. The first part of the course focuses on generation of population genetic data sets. The second part introduces the most common population genetic analyses and their theoretical background. Here topics include analysis of demography, population structure, recombination and selection. The last part of the course focus on applications of population genetic data sets for association studies in relation to human health.
Curriculum
The curriculum for each week is listed below. "Coop" refers to a set of lecture notes by Graham Coop that we will use throughout the course.
Course plan
Over the past year, biology educators and staff at the Department of Energy Systems Biology Knowledgebase (KBase) initiated a collaborative effort to develop a curriculum for bioinformatics education. KBase is a free and easily accessible data science platform that integrates many bioinformatics resources into a graphical user interface built upon reproducible analysis notebooks. KBase held conversations with college and high school instructors to understand how KBase could potentially support their educational goals. These conversations morphed into a working group of biological and data science instructors that adapted the KBase platform to their curriculum needs, specifically around concepts in Genomics, Metagenomics, Pangenomics, and Phylogenetics. The KBase Educators Working Group developed modular, adaptable, and customizable instructional units. Each instructional module contains teaching resources, publicly available data, analysis tools, and markdown capability to tailor instructions and learning goals for each class. The online user interface enables students to conduct hands-on data science research and analyses without requiring programming skills or their own computational resources (these are provided by KBase). Alongside these resources, KBase continues to work with instructors, supporting the development of additional curriculum modules. For anyone new to the platform, KBase, and the growing KBase Educators Organization, provides a community network, accompanied by community-sourced guidelines, instructional templates, and peer support to use KBase within a classroom whether virtual or in-person.
https://www.myvisajobs.com/terms-of-service/https://www.myvisajobs.com/terms-of-service/
A dataset that explores Green Card sponsorship trends, salary data, and employer insights for bioinformatics (computer science program) in the U.S.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
Provide a brief description of the dataset, including its purpose, context, and significance.
List and describe each column or key feature of the dataset.
Detail the format, size, and structure of the dataset.
This dataset is ideal for a variety of applications:
Explain the scope and coverage of the dataset:
CC0
List examples of intended users and their use cases:
Include any additional notes or context about the dataset that might be helpful for users.
The Network for Integrating Bioinformatics into Life Sciences Education (NIBLSE) seeks to promote the use of bioinformatics and data science as a way to teach biology.
https://www.statsndata.org/how-to-orderhttps://www.statsndata.org/how-to-order
The bioinformatics market has emerged as a pivotal domain at the intersection of biology and data science, playing an essential role in the analysis and interpretation of complex biological data. As the demand for genomic and proteomic data analysis continues to rise, bioinformatics offers innovative solutions for d
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Supplemental Data 1-S1. Timeline of important events shaping contemporary bioinformatics and comparative genomics. Timeline is not intended to be absolutely comprehensive of each of the observed fields, their respective histories. See footnotes for key review publications, sources in addition to those listed in Reference column. Field of contributions are color-coded accordingly: purple= computer science/engineering, blue= legislation/government action, biology= green, economic/markets= orange, academic institution= pink
The dataset was collected through whole-transcriptome RNA-Sequencing technologies. The processing method was described in the manuscript.
Explore the progression of average salaries for graduates in Science In Bioinformatics from 2020 to 2023 through this detailed chart. It compares these figures against the national average for all graduates, offering a comprehensive look at the earning potential of Science In Bioinformatics relative to other fields. This data is essential for students assessing the return on investment of their education in Science In Bioinformatics, providing a clear picture of financial prospects post-graduation.
Explore the progression of average salaries for graduates in Bioinformatics (Computer Science Program) from 2020 to 2023 through this detailed chart. It compares these figures against the national average for all graduates, offering a comprehensive look at the earning potential of Bioinformatics (Computer Science Program) relative to other fields. This data is essential for students assessing the return on investment of their education in Bioinformatics (Computer Science Program), providing a clear picture of financial prospects post-graduation.
Bioinformatics Market Size 2024-2028
The bioinformatics market size is forecast to increase by USD 13.2 billion at a CAGR of 16.59% between 2023 and 2028.
The market is experiencing significant growth, driven by the rapid advancements in genetic sequencing technology and the development of sophisticated bioinformatics tools for Next-Generation Sequencing (NGS). These innovations have led to a dramatic reduction in the cost of genetic sequencing, making it accessible to a wider range of researchers and organizations. However, this market is not without challenges. The shortage of trained laboratory professionals with expertise in bioinformatics and data analysis poses a significant barrier to the effective utilization of these advanced technologies. Companies seeking to capitalize on market opportunities must invest in training and development programs to address this talent gap.
Additionally, the increasing volume and complexity of genomic data require scalable and efficient bioinformatics solutions. Strategic partnerships, collaborations, and acquisitions can help companies overcome these challenges and gain a competitive edge in the market. Overall, the market presents significant opportunities for growth, particularly in areas such as personalized medicine, agricultural biotechnology, and environmental research. Companies that can effectively address the talent shortage and provide scalable, efficient solutions will be well-positioned to succeed in this dynamic and evolving market.
What will be the Size of the Bioinformatics Market during the forecast period?
Request Free Sample
The bioinformatics market, at the intersection of biology and computer science, is undergoing rapid growth, driven by next-generation sequencing (NGS), artificial intelligence (AI), and cloud computing. Clinical laboratories and research institutions leverage NGS for biomarker discovery, genetic testing, and protein sequencing, advancing precision medicine and population genetics. Bioinformatic pipelines and high-throughput screening manage omics data, supporting computational biology, evolutionary biology, and biomedical engineering.
Phylogenetic analysis and biological databases fuel scientific collaboration, while open access and cloud computing enhance data sharing. However, data security and data privacy remain critical challenges amid regulatory complexities. Biotechnology startups and digital health firms invest in single-cell sequencing, sequence alignment, and synthetic biology, developing mobile health applications and wearable devices.
Big data, gene editing, and genome editing drive innovation in biotechnology investment, while wet lab experiments complement in silico analyses. Market dynamics include rising demand for precision medicine, biotechnology startups, and digital health, with AI and NGS transforming clinical laboratories and scientific publications. Staying ahead requires addressing data privacy and embracing computational biology trends.
How is this Bioinformatics Industry segmented?
The bioinformatics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Application
Molecular phylogenetics
Proteomics
Metabolomics
Product
Platforms
Tools
Services
Genomics
Chemoinformatics & Drug Design
Others
Technology
Sequence Analysis
Data Warehousing
Structural Analysis
Geography
North America
US
Canada
Europe
France
Germany
UK
Middle East and Africa
UAE
APAC
China
India
Japan
South America
Brazil
By Application Insights
The molecular phylogenetics segment is estimated to witness significant growth during the forecast period.
In the realm of bioinformatics, molecular phylogenetics holds a pivotal position, particularly in the global market. This subfield of bioinformatics utilizes molecular data to elucidate the evolutionary relationships among various species. Its applications span numerous research domains, such as drug discovery, disease diagnosis, and conservation biology. One prominent area of application is the study of viral evolution. By deciphering the molecular data of diverse virus strains, researchers can trace their evolutionary history and gain valuable insights into their origins and transmission patterns. Next-generation sequencing technologies have significantly advanced molecular phylogenetics, enabling the analysis of vast amounts of genetic data.
Artificial intelligence and machine learning algorithms further enhance the accuracy and efficiency of these analyses. Clinical laboratories and research institutions employ these tools for genetic testing and biomarker discovery, driving the market's growth. Bioinformatics tools